This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement
Annals of Hematology Open Access 02 December 2021
-
Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia
Journal of Hematology & Oncology Open Access 27 March 2014
-
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
European Journal of Human Genetics Open Access 16 March 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Apperley JF, Gardembas M, Melo J, Russell-Jones R, Bain BJ, Baxter EJ et al. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N Engl J Med 2002; 347: 481–487.
Feng Y, Olson EC, Stukenberg PT, Flanagan LA, Kirschner MW, Walsh CA . LIS1 regulates CNS lamination by interacting with mNudE, a central component of the centrosome. Neuron 2000; 28: 665–679.
Feng Y, Walsh CA . Mitotic spindle regulation by Nde1 controls cerebral cortical size. Neuron 2004; 44: 279–293.
Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner MG, Kremer H et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan Syndrome. Nat Genet 2001; 29: 465–468.
Tartaglia M, Martinelli S, Iavarone I, Cazzaniga G, Spinelli M, Giarin E et al. Somatic PTPN11 mutations in childhood acute myeloid leukemia. Br J Haematol 2005; 129: 333–339.
Yamamoto T, Isomura M, Xu Y, Liang J, Yagasaki H, Kamachi Y et al. PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia. Leu Res 2006; 30: 1085–1089.
Acknowledgements
DNA clones were kindly provided by Dr F Birg, Institut Paoli-Calmettes, Marseille, France; by Dr M Rocchi, DAPEG, Sezione di Genetica, University of Bari, Italy; and by The Sanger Institute, Oxford, UK. The authors wish to thank Dr Geraldine Boyd for assistance in the preparation of this paper. This work was partially supported by MIUR (Ministero per l'Istruzione, l'Università e la Ricerca Scientifica), AIRC (Associazione Italiana Ricerca sul Cancro), FIRB (Fondo per gli Investimenti per la Ricerca di Base), Fondazione Cassa di Risparmio di Perugia, and Associazione ‘Sergio Luciani’, Fabriano, Italy; EU (European Community); Belgian Programme of Interuniversity Poles of Attraction initiated by Belgian State, Prime Minister's Office, Science Policy Programming and the Belgian Federation against Cancer. BC is a fellow of FIRC (Fondazione Italiana per la Ricerca sul Cancro).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
La Starza, R., Rosati, R., Roti, G. et al. A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome. Leukemia 21, 830–833 (2007). https://doi.org/10.1038/sj.leu.2404541
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404541
This article is cited by
-
Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement
Annals of Hematology (2022)
-
Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia
Journal of Hematology & Oncology (2014)
-
Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disorders
Leukemia (2012)
-
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
European Journal of Human Genetics (2011)
-
The NDE1 gene is disrupted by the inv(16) in 90% of cases with CBFB–MYH11-positive acute myeloid leukemia
Leukemia (2010)